AI startup ideas in Science
Scientific progress has been getting slower and more expensive per breakthrough. AI is the first tool in generations that could reverse that curve, but only if it is wired into experiments, field data and the institutions that fund and verify research.
These ideas push on that loop. They cover proof-of-impact funding for species recovery, practice-based evidence in psychedelic therapy, inner-voice neural interfaces and living biofiltration walls that double as research instruments. Each is scored on how much it could accelerate discovery and how directly that discovery reaches people.
4 open-sourced theses
DeepGuide
AI copilot for psychedelic therapy
Keeps facilitators present, captures structured notes, recommends the right exercise at the right moment, and turns outcomes into evolving best practices.
VIEW IDEA
BioWalls
Luxury Portals to the Natural World
Builds high-design living walls that turn dead interiors into luxury portals to the natural world, with optional animals, active biofiltration, and revenue flowing back to the real biome each wall represents.
VIEW IDEA
BioArk
Proof-of-Impact Funding for Species Recovery
A trust and funding platform for conservation breeding that routes capital to effective programs and proves positive biological impact.
VIEW IDEA
Thoughtline
Inner Voice AI & Interface
A personalized AI and neural-interface platform that helps shape your inner voice toward clarity, courage, calm, and focus, then lets you communicate with that AI at the speed of thought.
VIEW IDEANot sure which one is yours?
Answer six questions and get matched to the ideas that fit your skills, capital and conviction.
Unsolved science problems
High-priority gaps from the Problem Atlas that still need a founder.
Aging Biomarker Infrastructure
Priority 82We increasingly understand aging biology, but we still run medicine on late, noisy, disease-stage signals instead of tracking the pace of aging early and often.
Clinical Trial Execution OS
Priority 74We have therapeutic ideas, but clinical trials are still slow, expensive, and operationally brittle.
Scientific Integrity Tooling
Priority 72We are funding science as if peer review can keep up, but industrial-scale fraud is outpacing traditional quality control.
Machine-Actionable Research Artifacts
Priority 72We publish papers, but we do not reliably publish executable knowledge. Most science is still not machine-actionable, interoperable, or reusable.
Carbon Dioxide Removal MRV Standards
Priority 68Carbon dioxide removal is increasingly required in net-zero pathways, but the market lacks trusted measurement, monitoring, reporting, and verification (MRV), so buyers cannot confidently differentiate real tons from stories.